CLINICAL_TRIALS
trial_result
· 2010-01-06
Clinical Trial Update: MK0524B Bioequivalence Study (0524B-070) [Phase 1]
Summary
A Phase 1 bioequivalence study (0524B-070) for MK0524B in dyslipidemia has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Dyslipidemia | Phase 1 | Status: COMPLETED | Results posted: 2010-01-06